Nicole Harriott

USPTO Granted Patents = 13 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 30(Granted Patents)

Company Filing History:

8 out of 120

Neurocrine Biosciences, Inc.

patents

6 out of 1,535

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486250 - Muscarinic receptor 4 antagonists and methods of use (2025-12-02),

2. 11718618 - Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors (2023-08-08),

3. 11053242 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2021-07-06),

4. 11040970 - VMAT2 inhibitor compounds and compositions thereof (2021-06-22),

5. 11033539 - Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases (2021-06-15),

6. 9988382 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2018-06-05),

7. 9926308 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof (2018-03-27),

8. 9714246 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2017-07-25),

9. 9469631 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof (2016-10-18),

10. 8927726 - N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereof (2015-01-06),

11. 8921398 - N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof (2014-12-30),

12. 8822471 - Compounds, pharmaceutical compositions and uses thereof (2014-09-02),

13. 8293729 - Compounds, pharmaceutical composition and methods relating thereto (2012-10-23),

Title: The Innovative Contributions of Nicole Harriott in the Field of Pharmacology

Introduction: Nicole Harriott, based in San Diego, CA, is a notable inventor with a remarkable portfolio of 13 patents. Her groundbreaking work primarily focuses on the development of VMAT2 inhibitors, which have significant implications in treating various neurological conditions.

Latest Patents: Among her latest contributions are two patents for substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors. These disclosures relate to VMAT2 inhibitor compounds of formula (Ia), alongside pharmaceutically acceptable salts and the associated compositions and methods for their application. This innovative research lays the groundwork for potential new therapies targeting crucial neurotransmitter systems.

Career Highlights: Nicole has made substantial strides in her career, contributing her expertise to leading pharmaceutical companies. Noteworthy institutions include Neurocrine Biosciences, Inc. and Boehringer Ingelheim International GmbH. Her tenure at these organizations has been marked by her commitment to advancing pharmaceutical science.

Collaborations: Throughout her career, Nicole has collaborated with esteemed colleagues such as Neil Ashweek and Frank Himmelsbach. Their partnerships have been instrumental in enhancing the research and development of new therapeutic compounds, highlighting the importance of teamwork in the innovative process.

Conclusion: Nicole Harriott's exceptional contributions to the field of pharmacology, particularly through her patents and collaborative efforts, underscore her role as a pivotal innovator. With a strong foundation in VMAT2 inhibitor research, her work continues to pave the way for advancements in neurology and pharmacotherapy. The ongoing impact of her inventions promises to enrich the lives of many individuals affected by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.